Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorogenic Acid for Injection in Advanced Cancers
NCT02245204Phase 1Completed
- Sponsor
- Sichuan Jiuzhang Biotechnology
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of chlorogenic acid in cancer, sponsored by Sichuan Jiuzhang Biotechnology. Primary endpoint: Number of adverse events at 60 days. Started Sep 2014; status: completed.
02
Drugs
chlorogenic acid
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02245204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245204.